Concepedia
Statistics
Publications
22
Citations
1.3K
H-Index
18
Active since
2009
Affiliations
Goethe University Frankfurt(Current)
University Hospital Frankfurt
Georg Speyer Haus
National Research Centre
Nanosystem (Russia)
Thomas Pleli is an author at Goethe University Frankfurt specializing in medicine, oncology, and hepatocellular carcinoma.
Publications per year
2009–2020
High levels of the soluble programmed death-ligand (sPD-L1) identify hepatocellular carcinoma patients with a poor prognosis
Fabian Finkelmeier, Özge Canli, Andrea O. Tal et al. · European Journal of Cancer · 2016 · 203 citations
Medicine, Immunology, Oncology +17
Differential Stability of Cell-Free Circulating microRNAs: Implications for Their Utilization as Biomarkers
Verena Köberle, Thomas Pleli, Christian Schmithals et al. · PLoS ONE · 2013 · 196 citations · Full text
Life Sciences, Biochemistry, Molecular Biology +17
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma
Verena Köberle, Bernd Kronenberger, Thomas Pleli et al. · European Journal of Cancer · 2013 · 184 citations
Medicine, Cancer Biology, Oncology +14
Serum microRNA‐122 levels in different groups of patients with chronic hepatitis B virus infection
Oliver Waidmann, Verena Bihrer, Thomas Pleli et al. · Journal of Viral Hepatitis · 2011 · 125 citations
Medicine, Infectious Diseases, Molecular Biology +17
Serum Autotaxin Is a Parameter for the Severity of Liver Cirrhosis and Overall Survival in Patients with Liver Cirrhosis – A Prospective Cohort Study
Thomas Pleli, Daniel Martin, Bernd Kronenberger et al. · PLoS ONE · 2014 · 67 citations · Full text
Medicine, Pathobiology, Pathology +17
1–5 of 22